Download full-text PDF |
Source |
---|
Diabetes Res Clin Pract
January 2025
Department of Cardiovascular and Metabolic Diseases, Istituto Ricerca Cura Carattere Scientifico Multimedica, Sesto, San Giovanni (MI), Italy.
Primary prevention of diabetes still remains as an unmet challenge in a real world setting. While, translational programmes have been successful in the developed nations, the prevailing social and economic inequities in the low and middle income countries, fail to integrate diabetes prevention into their public health systems. The resulting exponential increase in the prevalence of diabetes and the cost of treatment has put primary prevention in the back seat.
View Article and Find Full Text PDFSci Total Environ
January 2025
Instituto Oceanográfico, Universidade de São Paulo, Praça do Oceanográfico, 191, São Paulo, SP 05508-120, Brazil.
J Biomed Opt
June 2024
Morgridge Institute for Research, Madison, Wisconsin, United States.
The editorial introduces the JBO special issue honoring Prof. Gabriel Popescu, Pioneer in Biomedical Optics.
View Article and Find Full Text PDFBlood Adv
November 2024
Ospedale Bambino Gesù, Rome, Italy.
The superiority of TBI-based versus chemotherapy-conditioning for allo-HSCT in children with ALL has been established in the international, prospective phase-III FORUM study (#NCT01949129), randomizing 417 patients ≤ 18 years at diagnosis (4-21 years at HSCT) in CR, transplanted from HLA-matched sibling or unrelated donors. Due to the unavailability of TBI in some regions and to accommodate individual contraindications, this study reports the pre-specified comparison of outcomes of patients receiving busulfan-based (BU) or treosulfan-based (TREO) regimens from 2013 to 2018. 180 and 128 patients (median age 9.
View Article and Find Full Text PDFOrphanet J Rare Dis
October 2024
Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, Porto Alegre, RS, 90035-903, Brazil.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!